{"id":"https://openalex.org/W4403255702","doi":"https://doi.org/10.1002/jimd.12795","title":"A phase III , open\u2010label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies","display_name":"A phase III , open\u2010label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies","publication_year":2024,"publication_date":"2024-10-09","ids":{"openalex":"https://openalex.org/W4403255702","doi":"https://doi.org/10.1002/jimd.12795","pmid":"https://pubmed.ncbi.nlm.nih.gov/39381863","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11667655"},"language":"en","primary_location":{"id":"doi:10.1002/jimd.12795","doi":"https://doi.org/10.1002/jimd.12795","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jimd.12795","pdf_url":null,"source":{"id":"https://openalex.org/S186577254","display_name":"Journal of Inherited Metabolic Disease","issn_l":"0141-8955","issn":["0141-8955","1573-2665"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Inherited Metabolic Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1002/jimd.12795","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109600496","display_name":"Myrl D. Holida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myrl Holida","raw_affiliation_strings":["Division of Medical Genetics and Genomics, Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Genetics and Genomics, Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075282771","display_name":"Ale\u0161 Linhart","orcid":"https://orcid.org/0000-0002-3372-7850","observed_orcids":["https://orcid.org/0000-0002-3372-7850"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210162037","display_name":"General University Hospital in Prague","ror":"https://ror.org/04yg23125","country_code":"CZ","type":"funder","lineage":["https://openalex.org/I4210162037"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Ale\u0161 Linhart","raw_affiliation_strings":["Charles University, General University Hospital, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles University, General University Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210162037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064838336","display_name":"Antonio Pisani","orcid":"https://orcid.org/0000-0003-0241-8323","observed_orcids":["https://orcid.org/0000-0003-0241-8323"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Pisani","raw_affiliation_strings":["Department of Public Health, University Federico II of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health, University Federico II of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102908490","display_name":"Nicola Longo","orcid":"https://orcid.org/0000-0002-3677-1216","observed_orcids":["https://orcid.org/0000-0002-3677-1216"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicola Longo","raw_affiliation_strings":["Pediatrics Medical Genetics, University of Utah, Salt Lake City, Utah, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatrics Medical Genetics, University of Utah, Salt Lake City, Utah, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055841171","display_name":"Fran\u00e7ois J.M. Eyskens","orcid":"https://orcid.org/0000-0001-6062-6150","observed_orcids":["https://orcid.org/0000-0001-6062-6150","https://orcid.org/0000-0003-3981-0142"]},"institutions":[{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"funder","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Eyskens","raw_affiliation_strings":["Antwerp University Hospital UZA, Edegem, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antwerp University Hospital UZA, Edegem, Belgium","institution_ids":["https://openalex.org/I4210102047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067876029","display_name":"\u00d6zlem G\u00f6ker-Alpan","orcid":"https://orcid.org/0000-0003-4758-6793","observed_orcids":["https://orcid.org/0000-0003-4758-6793"]},"institutions":[{"id":"https://openalex.org/I4210106088","display_name":"Lysosomal and Rare Disorders Research and Treatment Center","ror":"https://ror.org/01m3cg403","country_code":"US","type":"other","lineage":["https://openalex.org/I4210106088"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ozlem Goker\u2010Alpan","raw_affiliation_strings":["Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, Virginia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, Virginia, USA","institution_ids":["https://openalex.org/I4210106088"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111226805","display_name":"Eric L Wallace","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Wallace","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, Alabama, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, Alabama, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008014564","display_name":"Patrick B. Deegan","orcid":"https://orcid.org/0000-0001-9427-9900","observed_orcids":["https://orcid.org/0000-0001-9427-9900"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Patrick Deegan","raw_affiliation_strings":["Lysosomal Disorders Unit, Cambridge University Hospitals NHS Foundation Trust and University of Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lysosomal Disorders Unit, Cambridge University Hospitals NHS Foundation Trust and University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I2802466933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054028455","display_name":"Camilla T\u00f8ndel","orcid":"https://orcid.org/0000-0003-3389-3194","observed_orcids":["https://orcid.org/0000-0003-3389-3194"]},"institutions":[{"id":"https://openalex.org/I2800740805","display_name":"Haukeland University Hospital","ror":"https://ror.org/03np4e098","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I2800740805"]},{"id":"https://openalex.org/I4432739","display_name":"University of Bergen","ror":"https://ror.org/03zga2b32","country_code":"NO","type":"education","lineage":["https://openalex.org/I4432739"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Camilla T\u00f8ndel","raw_affiliation_strings":["University of Bergen and Haukeland University Hospital, Bergen, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bergen and Haukeland University Hospital, Bergen, Norway","institution_ids":["https://openalex.org/I2800740805","https://openalex.org/I4432739"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085122960","display_name":"Ulla Feldt\u2010Rasmussen","orcid":"https://orcid.org/0000-0002-5903-3355","observed_orcids":["https://orcid.org/0000-0002-5903-3355"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Ulla Feldt\u2010Rasmussen","raw_affiliation_strings":["Department of Endocrinology and Metabolism, Rigshospitalet and Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Rigshospitalet and Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016812185","display_name":"Derralynn A. Hughes","orcid":"https://orcid.org/0000-0003-4531-9173","observed_orcids":["https://orcid.org/0000-0003-4531-9173"]},"institutions":[{"id":"https://openalex.org/I169248724","display_name":"Royal Free London NHS Foundation Trust","ror":"https://ror.org/04rtdp853","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Derralynn Hughes","raw_affiliation_strings":["LSDU, Royal Free London NHS Foundation Trust, and University College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LSDU, Royal Free London NHS Foundation Trust, and University College London, London, UK","institution_ids":["https://openalex.org/I169248724","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089304963","display_name":"Anat Sakov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anat Sakov","raw_affiliation_strings":["DataSights Ltd, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DataSights Ltd, Haifa, Israel","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049671864","display_name":"Rossana Rocco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rossana Rocco","raw_affiliation_strings":["Chiesi Farmaceutici S.p.A, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Farmaceutici S.p.A, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040454097","display_name":"Einat Brill Almon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800399356","display_name":"Protalix BioTherapeutics (Israel)","ror":"https://ror.org/02jf3v234","country_code":"IL","type":"company","lineage":["https://openalex.org/I2800399356"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Einat Brill Almon","raw_affiliation_strings":["Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel","institution_ids":["https://openalex.org/I2800399356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104033760","display_name":"Sari Alon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800399356","display_name":"Protalix BioTherapeutics (Israel)","ror":"https://ror.org/02jf3v234","country_code":"IL","type":"company","lineage":["https://openalex.org/I2800399356"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Sari Alon","raw_affiliation_strings":["Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel","institution_ids":["https://openalex.org/I2800399356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091262663","display_name":"Raul Chertkoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800399356","display_name":"Protalix BioTherapeutics (Israel)","ror":"https://ror.org/02jf3v234","country_code":"IL","type":"company","lineage":["https://openalex.org/I2800399356"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Raul Chertkoff","raw_affiliation_strings":["Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel","institution_ids":["https://openalex.org/I2800399356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029720798","display_name":"David G. Warnock","orcid":"https://orcid.org/0000-0003-4112-0677","observed_orcids":["https://orcid.org/0000-0003-4112-0677"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David G. Warnock","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, Alabama, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, Alabama, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087123106","display_name":"Stephen Waldek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5728261","display_name":"University of Sunderland","ror":"https://ror.org/04p55hr04","country_code":"GB","type":"education","lineage":["https://openalex.org/I5728261"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Waldek","raw_affiliation_strings":["University of Sunderland, Sunderland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Sunderland, Sunderland, UK","institution_ids":["https://openalex.org/I5728261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008798978","display_name":"William Ross Wilcox","orcid":"https://orcid.org/0000-0002-0325-0377","observed_orcids":["https://orcid.org/0000-0002-0325-0377"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William R. Wilcox","raw_affiliation_strings":["Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052375217","display_name":"John A. Bernat","orcid":"https://orcid.org/0000-0003-2033-6129","observed_orcids":["https://orcid.org/0000-0003-2033-6129"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John A. Bernat","raw_affiliation_strings":["Division of Medical Genetics and Genomics, Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA"],"raw_orcid":"https://orcid.org/0000-0003-2033-6129","affiliations":[{"raw_affiliation_string":"Division of Medical Genetics and Genomics, Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":20,"corresponding_author_ids":["https://openalex.org/A5052375217"],"corresponding_institution_ids":["https://openalex.org/I126307644"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":5.1606,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.96488024,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"48","issue":"1","first_page":"e12795","last_page":"e12795"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fabry-disease","display_name":"Fabry disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pegunigalsidase-alfa","display_name":"pegunigalsidase alfa","score":0.9990000128746033},{"id":"https://openalex.org/keywords/enzyme-replacement-therapy","display_name":"enzyme replacement therapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/extended-dosing-interval","display_name":"extended dosing interval","score":0.7900000214576721},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8050000071525574},{"id":"https://openalex.org/keywords/lyso-gb3","display_name":"lyso-Gb3","score":0.7369999885559082},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.7329999804496765},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.824999988079071},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.44600000977516174},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C2779969927","wikidata":"https://www.wikidata.org/wiki/Q916766","display_name":"Enzyme replacement therapy","level":3,"score":0.805109441280365},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.781446099281311},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6457650661468506},{"id":"https://openalex.org/C2777404818","wikidata":"https://www.wikidata.org/wiki/Q615645","display_name":"Fabry disease","level":3,"score":0.6261284351348877},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6156526207923889},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.587225079536438},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4632946252822876},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4441913366317749},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4218248724937439},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36346131563186646},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20776861906051636}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000519","descriptor_name":"alpha-Galactosidase","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000519","descriptor_name":"alpha-Galactosidase","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000795","descriptor_name":"Fabry Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006017","descriptor_name":"Glycolipids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013107","descriptor_name":"Sphingolipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014281","descriptor_name":"Trihexosylceramides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056947","descriptor_name":"Enzyme Replacement Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1002/jimd.12795","doi":"https://doi.org/10.1002/jimd.12795","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jimd.12795","pdf_url":null,"source":{"id":"https://openalex.org/S186577254","display_name":"Journal of Inherited Metabolic Disease","issn_l":"0141-8955","issn":["0141-8955","1573-2665"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Inherited Metabolic Disease","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11667655","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11667655","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11667655/pdf/JIMD-48-0.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Inherit Metab Dis","raw_type":"Text"},{"id":"pmid:39381863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39381863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of inherited metabolic disease","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/f4642c39-ca91-46e6-9322-a437afcd5387","doi":null,"is_oa":true,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/f4642c39-ca91-46e6-9322-a437afcd5387","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:sure.sunderland.ac.uk:18365","doi":null,"is_oa":true,"landing_page_url":"http://sure.sunderland.ac.uk/view/creators/Holida=3AMyrl=3A=3A.html>,","pdf_url":"https://sure.sunderland.ac.uk/id/eprint/18365/3/J%20of%20Inher%20Metab%20Disea%20-%202024%20-%20Holida%20-%20A%20phase%20III%20open%E2%80%90label%20clinical%20trial%20evaluating%20pegunigalsidase%20alfa.pdf","source":{"id":"https://openalex.org/S4306402295","display_name":"Sunderland Repository (University of Sunderland)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5728261","host_organization_name":"University of Sunderland","host_organization_lineage":["https://openalex.org/I5728261"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/374758","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/374758","pdf_url":"https://www.repository.cam.ac.uk/bitstreams/591c1065-66f1-4288-b9f0-2e14ae86cadd/download","source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1002/jimd.12795","doi":"https://doi.org/10.1002/jimd.12795","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jimd.12795","pdf_url":null,"source":{"id":"https://openalex.org/S186577254","display_name":"Journal of Inherited Metabolic Disease","issn_l":"0141-8955","issn":["0141-8955","1573-2665"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Inherited Metabolic Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309888","display_name":"Chiesi Farmaceutici","ror":"https://ror.org/0511bn634"},{"id":"https://openalex.org/F4320310557","display_name":"BioMarin Pharmaceutical","ror":"https://ror.org/03fmvqd28"},{"id":"https://openalex.org/F4320315747","display_name":"Amicus Therapeutics","ror":"https://ror.org/0328xw886"},{"id":"https://openalex.org/F4320317951","display_name":"Sangamo Therapeutics","ror":"https://ror.org/046dwx283"},{"id":"https://openalex.org/F4320319101","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37"},{"id":"https://openalex.org/F4320319595","display_name":"Chiesi USA","ror":"https://ror.org/037dejx04"},{"id":"https://openalex.org/F4320329429","display_name":"Idorsia Pharmaceuticals","ror":"https://ror.org/03va9ng43"},{"id":"https://openalex.org/F4320334149","display_name":"Spark Therapeutics","ror":"https://ror.org/00s93j442"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403255702.pdf","grobid_xml":"https://content.openalex.org/works/W4403255702.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1790440725","https://openalex.org/W1968391529","https://openalex.org/W1984182083","https://openalex.org/W1998571394","https://openalex.org/W2015981234","https://openalex.org/W2022356406","https://openalex.org/W2039770589","https://openalex.org/W2041953538","https://openalex.org/W2082623163","https://openalex.org/W2101510401","https://openalex.org/W2104742273","https://openalex.org/W2118558603","https://openalex.org/W2154973949","https://openalex.org/W2155965977","https://openalex.org/W2160213856","https://openalex.org/W2165232003","https://openalex.org/W2500404244","https://openalex.org/W2536972320","https://openalex.org/W2551668015","https://openalex.org/W2787624857","https://openalex.org/W2808184073","https://openalex.org/W2918551192","https://openalex.org/W3048769998","https://openalex.org/W3113542701","https://openalex.org/W3152508416","https://openalex.org/W3212677890","https://openalex.org/W4211146209","https://openalex.org/W4285491963","https://openalex.org/W4289080117","https://openalex.org/W4308259963","https://openalex.org/W4308487363","https://openalex.org/W4386134893","https://openalex.org/W4387847834","https://openalex.org/W4388501088"],"related_works":["https://openalex.org/W7138871425","https://openalex.org/W4319459676","https://openalex.org/W4387847834","https://openalex.org/W2914750479","https://openalex.org/W2918551192","https://openalex.org/W6911246999","https://openalex.org/W2911656600","https://openalex.org/W4396998190","https://openalex.org/W4386134893","https://openalex.org/W4324117204"],"abstract_inverted_index":{"Abstract":[0],"Pegunigalsidase":[1,88],"alfa,":[2],"a":[3,15,31,198,283],"PEGylated":[4],"\u03b1\u2010galactosidase":[5],"A":[6],"enzyme":[7],"replacement":[8],"therapy":[9],"(ERT)":[10],"for":[11,49,63,260,287],"Fabry":[12,39,224,290],"disease,":[13,40],"has":[14],"longer":[16],"plasma":[17,90],"half\u2010life":[18],"than":[19],"other":[20],"ERTs":[21],"administered":[22],"intravenously":[23],"every":[24,59,278],"2":[25,55,211,274],"weeks":[26,61,141,280],"(E2W).":[27],"BRIGHT":[28,206],"(NCT03180840)":[29],"was":[30,142,169],"phase":[32],"III,":[33],"open\u2010label":[34],"study":[35,207],"in":[36,195,201,219,233,259],"adults":[37],"with":[38,43,197,223,273,289],"previously":[41,84],"treated":[42],"agalsidase":[44,86],"alfa":[45,58,89,214,246,277],"or":[46],"beta":[47],"E2W":[48],"\u22653":[50],"years,":[51],"who":[52],"switched":[53],"to":[54,227,240,262,268],"mg/kg":[56,212,275],"pegunigalsidase":[57,213,245,276],"4":[60,279],"(E4W)":[62],"52":[64,140],"weeks.":[65],"Primary":[66],"objective":[67],"assessed":[68],"safety,":[69],"including":[70],"number":[71,230],"of":[72,97,105,231,244,252],"treatment\u2010emergent":[73],"adverse":[74],"events":[75],"(TEAEs).":[76],"Thirty":[77],"patients":[78,118,222,232,288],"were":[79,111,115,191],"enrolled":[80],"(24":[81],"males);":[82],"23":[83],"received":[85],"beta.":[87],"concentrations":[91,190],"remained":[92],"above":[93],"the":[94,100,126,228,242,264],"lower":[95],"limit":[96],"quantification":[98],"throughout":[99],"4\u2010week":[101],"dosing":[102],"interval.":[103],"Thirty\u2010three":[104],"182":[106],"TEAEs":[107],"(in":[108],"9":[109],"patients)":[110],"considered":[112],"treatment\u2010related;":[113],"all":[114],"mild/moderate.":[116],"No":[117],"developed":[119],"de":[120],"novo":[121],"anti\u2010drug":[122],"antibodies":[123],"(ADAs).":[124],"In":[125],"efficacy":[127],"analysis":[128],"(n":[129,148],"=":[130,149,153,160,177,184],"29),":[131],"median":[132,166],"(inter\u2010quartile":[133],"range)":[134],"eGFR":[135,167],"change":[136],"from":[137],"baseline":[138],"over":[139],"\u22121.9":[143],"(\u22125.9;":[144],"1.8)":[145],"mL/min/1.73":[146,173],"m2":[147],"28;":[150],"males":[151,202],"[n":[152,159,176,183],"22]:":[154],"\u20132.4":[155],"[\u22125.2;":[156],"3.2];":[157],"females":[158],"6]:":[161],"\u22120.7":[162],"[\u22129.2;":[163],"2.0]).":[164],"Overall,":[165],"slope":[168],"\u20131.9":[170],"(\u22128.3;":[171],"1.9)":[172],"m2/year":[174],"(ADA\u2010negative":[175],"20]:":[178],"\u22121.2":[179],"[\u22126.4;":[180],"2.6];":[181],"ADA\u2010positive":[182],"9]:":[185],"\u22128.4":[186],"[\u221211.6;":[187],"\u20131.0]).":[188],"Lyso\u2010Gb3":[189],"low":[192,229],"and":[193],"stable":[194,220],"females,":[196],"slight":[199],"increase":[200],"(9/24":[203],"ADA\u2010positive).":[204],"The":[205],"results":[208],"suggest":[209],"that":[210],"E4W":[215],"is":[216,238],"tolerated":[217],"well":[218],"adult":[221],"disease.":[225,291],"Due":[226],"this":[234,253],"study,":[235],"more":[236],"research":[237],"needed":[239],"demonstrate":[241],"effects":[243],"given":[247],"E4W.":[248,269],"Further":[249],"evidence,":[250],"outside":[251],"clinical":[254],"trial,":[255],"should":[256],"be":[257],"factored":[258],"physicians":[261],"prolong":[263],"biweekly":[265],"ERT":[266],"intervals":[267],"Take\u2010home":[270],"message":[271],"Treatment":[272],"could":[281],"offer":[282],"new":[284],"treatment":[285],"option":[286]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2024-10-10T00:00:00"}